Clinical Trial Update: Prophylactic Transfer of Leukemia-reactive T Cells After Allogeneic Transplantation [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports on a completed Phase 1/2 study evaluating prophylactic transfer of leukemia-reactive T cells after allogeneic transplantation…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Snippet

Sponsor: University Hospital Carl Gustav Carus | Conditions: Chronic Myeloid Leukemia | Phase 1, Phase 2 | Status: COMPLETED